The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy

NANot yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2026

Conditions
Opioid Use DisorderPolysubstance AddictionSubstance Use
Interventions
BEHAVIORAL

OpiVenture

"OpiVenture, a targeted psychosocial intervention, complements opioid agonist therapy for opioid use disorder. Adapted from proven interventions like PreVenture, it unfolds over three sessions. Session one covers introductions, an ice-breaker, trait overview, strengths/limitations discussion, goal setting, and homework. Session two reviews homework, explores coping strategies, weighs alternatives, introduces hot thoughts, reviews trait-specific hot thoughts, and assigns homework. The concluding session involves reviewing homework, identifying personal hot thoughts, challenging them through a cognitive-behavioral exercise, applying insights to goal setting, and concluding with a wrap-up."

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

"Direction 180

UNKNOWN

collaborator

Centre for Research, Education, and Clinical Care of At-Risk Populations (RECAP)

UNKNOWN

collaborator

River Stone Recovery Centre

UNKNOWN

collaborator

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

OTHER

collaborator

Université de Montréal

OTHER

collaborator

University of New Brunswick

OTHER

lead

Dalhousie University

OTHER

NCT06211972 - The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy | Biotech Hunter | Biotech Hunter